{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:36:24Z","timestamp":1790742984547,"version":"4.1.0"},"reference-count":55,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5551\/jat.34082","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T22:04:48Z","timestamp":1459893888000},"page":"1294-1306","source":"Crossref","is-referenced-by-count":29,"title":["Intermedin<sub>1\u201353<\/sub> Protects Against Myocardial Fibrosis by Inhibiting Endoplasmic Reticulum Stress and Inflammation Induced by Homocysteine in Apolipoprotein E-Deficient Mice"],"prefix":"10.5551","volume":"23","author":[{"given":"Jin-Sheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center"},{"name":"Laboratory of Cardiovascular Bioactive Molecule, School of Basic Medical Sciences, Peking University"},{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Long","family":"Hou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center"},{"name":"Laboratory of Cardiovascular Bioactive Molecule, School of Basic Medical Sciences, Peking University"},{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Lu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center"},{"name":"Laboratory of Cardiovascular Bioactive Molecule, School of Basic Medical Sciences, Peking University"},{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Qiang","family":"Ni","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center"},{"name":"Laboratory of Cardiovascular Bioactive Molecule, School of Basic Medical Sciences, Peking University"},{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Respiratory Disease, Peking University Third Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Rong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Shu","family":"Tang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center"},{"name":"Laboratory of Cardiovascular Bioactive Molecule, School of Basic Medical Sciences, Peking University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Fen","family":"Qi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center"},{"name":"Laboratory of Cardiovascular Bioactive Molecule, School of Basic Medical Sciences, Peking University"},{"name":"Department of Pathogen Biology, School of Basic Medical Sciences, Peking University Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lee TM, Chou TF, Tsai CH: Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-isoprostaglandin f2alpha formation. J Cardiovasc Pharmacol, 2002; 40: 868-874","DOI":"10.1097\/00005344-200212000-00007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sundstr\u00f6m J, Lind L, Vessby B, Andr\u00e9n B, Aro A, Lithell H: Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation, 2001; 103: 836-841","DOI":"10.1161\/01.CIR.103.6.836"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wang YX: Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice. Neurobiol Aging, 2005; 26: 309-316","DOI":"10.1016\/j.neurobiolaging.2004.06.018"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb, 1994; 14: 133-140","DOI":"10.1161\/01.ATV.14.1.133"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shenov V, Mehendale V, Prabhu K, Shetty R, Rao P: Correlation of serum homocysteine levels with the severity of coronary artery disease. Ind J Clin Biochem, 2014; 29: 339-344","DOI":"10.1007\/s12291-013-0373-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kumakura H, Fujita K, Kanai H, Araki Y, Hojo Y, Kasama S, Iwasaki T, Ichikawa S, Nakashima K, Minami K: High-sensitivity C-reactive Protein, Lipoprotein (a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease. J Atheroscler Thromb, 2015; 22: 344-354","DOI":"10.5551\/jat.25478"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Raaf L, Noll C, Cherifi Mel H, Samuel JL, Delcayre C, Delabar JM, Benazzoug Y, Janel N: Myocardial fibrosis and TGFB expression in hyperhomocysteinemic rats. Mol Cell Biochem, 2011; 347: 63-70","DOI":"10.1007\/s11010-010-0612-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Peer M, Boaz M, Zipora M, Shargorodsky M: Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors. Int J Angiol, 2013; 22: 223-228","DOI":"10.1055\/s-0033-1348880"},{"key":"9","unstructured":"9) Kharlamova UV, Il'icheva OE: Effect of homocysteine on left ventricular structural and functional parameters in patients on programmed hemodialysis. Ter Arkh, 2013; 85: 90-93"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Pal Singh A, Kaur T, SinghDahiya R, Singh N, Singh Bedi PM: Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy. J Cardiovasc Pharmacol, 2010; 56: 53-59","DOI":"10.1097\/FJC.0b013e3181de308b"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kassab S, Garadah T, Abu-Hijleh M, Golbahar J, Senok S, Wazir J, Gumaa K: The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats. J Renin Angiotensin Aldosterone Syst, 2006; 7: 206-211","DOI":"10.3317\/jraas.2006.039"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhi H, Luptak I, Alreja G, Shi J, Guan J, Metes-Kosik N, Joseph J: Effects of direct Renin inhibition on myocardial fibrosis and cardiac fibroblast function. PLoS One, 2013; 8: e81612","DOI":"10.1371\/journal.pone.0081612"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lenna S, Trojanowska M: The role of endoplasmic reticulum stress and the unfolded protein response in fibrosis. Curr Opin Rheumatol, 2012; 24: 663-668","DOI":"10.1097\/BOR.0b013e3283588dbb"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Szegezdi E, Logue SE, Gorman AM, Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep, 2006; 7: 880-885","DOI":"10.1038\/sj.embor.7400779"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Tanjore H, Lawson WE, Blackwell TS: Endoplasmic reticulum stress as a pro-fibrotic stimulus. Biochim Biophys Acta, 2013; 1832: 940-947","DOI":"10.1016\/j.bbadis.2012.11.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yoshida H: ER stress and diseases. FEBS J, 2007; 274: 630-658","DOI":"10.1111\/j.1742-4658.2007.05639.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Duan X, Zhou Y, Teng X, Tang C, Qi Y: Endoplasmic reticulum stress mediated apoptosis is activated in vascular calcification. Biochem Biophys Res Commun, 2009; 387: 694-699","DOI":"10.1016\/j.bbrc.2009.07.085"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ayala P, Montenegro J, Vivar R, Letelier A, Urroz PA, Copaja M, Pivet D, Humeres C, Troncoso R, Vicencio JM, Lavandero S, D\u00edaz-Araya G: Attenuation of endoplasmic reticulum stress using the chemical chaperone 4-phenylbutyric acid prevents cardiac fibrosis induced by isoproterenol. Exp Mol Pathol, 2012; 92: 97-104","DOI":"10.1016\/j.yexmp.2011.10.012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kassan M, Gal\u00e1n M, Partyka M, Saifudeen Z, Henrion D, Trebak M, Matrougui K: Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. Arterioscler Thromb Vasc Biol, 2012; 32: 1652-1661","DOI":"10.1161\/ATVBAHA.112.249318"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Dobaczewski M, Frangogiannis NG: Chemokines and cardiac fibrosis. Front Biosci (Schol Ed), 2009; 1: 391-405","DOI":"10.2741\/s33"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Jia L, Li Y, Xiao C, Du J: Angiotensin II induces inflammation leading to cardiac remodeling. Front Biosci (Landmark Ed), 2012; 17: 221-231","DOI":"10.2741\/3923"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ma F, Li Y, Jia L, Han Y, Cheng J, Li H, Qi Y, Du J: Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One, 2012; 7: e35144","DOI":"10.1371\/journal.pone.0035144"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bujak M, Frangogiannis NG: The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res, 2007; 74: 184-195","DOI":"10.1016\/j.cardiores.2006.10.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Doroudgar S, Glembotski CC: The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol Med, 2011; 17: 207-214","DOI":"10.1016\/j.molmed.2010.12.003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Miyahara Y, Ishibashi-Ueda H, Aizawa Y, Kangawa K, Nagaya N: Infusion of adrenomedullin improves acute myocarditis via attenuation of myocardial inflammation and edema. Cardiovasc Res, 2007; 76: 110-118","DOI":"10.1016\/j.cardiores.2007.05.027"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ni X, Zhang J, Tang C, Qi Y: Intermedin\/adrenomedullin2: an autocrine\/paracrine factor in vascular homeostasis and disease. Sci China Life Sci, 2014; 57: 781-789","DOI":"10.1007\/s11427-014-4701-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Koyama T, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Shindo T: Adrenomedullin-RAMP2 System in Vascular Endothelial Cells. J Atheroscler Thromb, 2015; 22: 647-653","DOI":"10.5551\/jat.29967"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Yang JH, Cai Y, Duan XH, Ma CG, Wang X, Tang CS, Qi YF: Intermedin1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II. Regul Pept, 2009; 158: 19-25","DOI":"10.1016\/j.regpep.2009.05.012"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Yang JH, Ma CG, Cai Y, Pan CS, Zhao J, Tang CS, Qi YF: Effect of intermedin1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes. J Cardiovasc Pharmacol, 2010; 56: 45-52","DOI":"10.1097\/FJC.0b013e3181ddc785"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Chang JR, Duan XH, Zhang BH, Teng X, Zhou YB, Liu Y, Yu YR, Zhu Y, Tang CS, Qi YF: Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate\/protein kinase A pathway. Exp Biol Med (Maywood), 2013; 238: 1136-1146","DOI":"10.1177\/1535370213502619"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Teng X, Song J, Zhang G, Cai Y, Yuan F, Du J, Tang C, Qi Y: Inhibition of endoplasmic reticulum stress by intermedin(1-53) protects against myocardial injury through a PI3 kinase-Akt signaling pathway. J Mol Med (Berl), 2011; 89: 1195-1205","DOI":"10.1007\/s00109-011-0808-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Hagiwara M, Bledsoe G, Yang ZR, Smith RS Jr, Chao L, Chao J: Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. Am J Physiol Renal Physiol, 2008; 295: F1735-1743","DOI":"10.1152\/ajprenal.90427.2008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Li H, Bian Y, Zhang N, Guo J, Wang C, Lau WB, Xiao C: Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats. Cardiovasc Diabetol, 2013; 12: 91","DOI":"10.1186\/1475-2840-12-91"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yang SM, Liu J, Li CX: Intermedin protects against myocardial ischemia-reperfusion injury in hyperlipidemia rats. Genet Mol Res, 2014; 13: 8309-8319","DOI":"10.4238\/2014.October.20.7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J, Xiang X, Kong W, Xu G, Li Y, Wang X: Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem, 2013; 288: 9583-9592","DOI":"10.1074\/jbc.M112.431627"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Zhou J, M\u00f8ller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, Falk E: Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol, 2001; 21: 1470-1476","DOI":"10.1161\/hq0901.096582"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Qin YW, Ye P, He JQ, Sheng L, Wang LY, Du J: Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a \u201cWestern-style diet\u201d by increasing PPAR \u03b1 and \u03b3 expression and reducing TC, MMP-9, and Cat S levels. Acta Pharmacol Sin, 2010; 31: 1350-1358","DOI":"10.1038\/aps.2010.109"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Nishikimi T, Tadokoro K, Akimoto K, Mori Y, Ishikawa Y, Ishimura K, Horio T, Kangawa K, Matsuoka H: Response of adrenomedullin system to cytokine in cardiac fibroblasts-role of adrenomedullin as an antifibrotic factor. Cardiovasc Res, 2005; 66: 104-113","DOI":"10.1016\/j.cardiores.2004.12.015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Zhao L, Peng DQ, Zhang J, Song JQ, Teng X, Yu YR, Tang CS, Qi YF: Extracellular signal-regulated kinase 1\/2 activation is involved in intermedin1-53 attenuating myocardial oxidative stress injury induced by ischemia\/reperfusion. Peptides, 2012; 33: 329-335","DOI":"10.1016\/j.peptides.2011.12.016"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Chen H, Wang X, Tong M, Wu D, Wu S, Chen J, Wang X, Wang X, Kang Y, Tang H, Tang C, Jiang W: Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy. PLoS One, 2013; 8: e64757","DOI":"10.1371\/journal.pone.0064757"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Pah HL: Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol Rev, 1999; 79: 683-701","DOI":"10.1152\/physrev.1999.79.3.683"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Pavitt GD, Ron D: New insights into translational regulation in the endoplasmic reticulum unfolded protein response. Cold Spring Harb Perspect Biol, 2012; 4. pii: a012278","DOI":"10.1101\/cshperspect.a012278"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Schr\u00f6der M: Endoplasmic reticulum stress responses. Cell Mol Life Sci, 2008; 65: 862-894","DOI":"10.1007\/s00018-007-7383-5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Veeranki S, Tyagi SC: Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int J Mol Sci, 2013; 14: 15074-15091","DOI":"10.3390\/ijms140715074"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Ho YY, Lagares D, Tager AM, Kapoor M: Fibrosis--a lethal component of systemic sclerosis. Nat Rev Rheumatol, 2014; 10: 390-402","DOI":"10.1038\/nrrheum.2014.53"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) van Nieuwenhoven FA, Turner NA: The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol, 2013; 58: 182-188","DOI":"10.1016\/j.vph.2012.07.003"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Nattel S, Burstein B, Dobrev D: Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol, 2008; 1: 62-73","DOI":"10.1161\/CIRCEP.107.754564"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Thum T, Lorenzen JM: Cardiac fibrosis revisited by microRNA therapeutics. Circulation, 2012; 126: 800-802","DOI":"10.1161\/CIRCULATIONAHA.112.125013"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Jin D, Otani K, Yamahara K, Ikeda T, Nagaya N, Kangawa K: Adrenomedullin reduces expression of adhesion molecules on lymphatic endothelial cells. Regul Pept, 2011; 166: 21-27","DOI":"10.1016\/j.regpep.2010.08.003"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Parry GC, Mackman N: Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol, 1997; 159: 5450-5456","DOI":"10.4049\/jimmunol.159.11.5450"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Talero E, Di Paola R, Mazzon E, Esposito E, Motilva V, Cuzzocrea S: Anti-inflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice. Mediators Inflamm, 2012; 2012: 717851","DOI":"10.1155\/2012\/717851"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Gonzalez-Rey E, Chorny A, Delgado M: Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol, 2007; 7: 52-63","DOI":"10.1038\/nri1984"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER: Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol, 2010; 24: 2152-2165","DOI":"10.1210\/me.2010-0154"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Hammes SR, Levin ER: Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology, 2011; 152: 4489-4495","DOI":"10.1210\/en.2011-1470"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Schattenberg JM, Czaja MJ: Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling. Redox Biol, 2014; 3: 7-15","DOI":"10.1016\/j.redox.2014.09.004"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/23\/11\/23_34082\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T14:01:43Z","timestamp":1692280903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/23\/11\/23_34082\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.34082","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}